FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA
Apr 14, 2024, 03:08 |
Societies
Vivek Subbiah: The future of cancer research shines brightly!
Quoting Vivek Subbiah on X/Twitter: "The future of cancer research shines brightly! It was an honor…
Apr 14, 2024, 02:26 |
Insight
Vivek Subbiah: A pan-cancer analysis of the microbiome in metastatic cancer
Quoting Vivek Subbiah on X/Twitter: "A pan-cancer analysis of the microbiome in metastatic cancer: Cell.…
Apr 13, 2024, 08:14 |
Blog
David Fajgenbaum: Did you know behind every FDA approved drug lies numerous potential disease applications considered by drug companies?
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
Apr 12, 2024, 16:21 |
Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 12, 2024, 11:31 |
Blog
Scott Gottlieb: I had the opportunity to discuss the accelerated approval of cancer drugs on CNBC and share insights from a recent JAMA study
Scott Gottlieb, Partner at New Enterprise Associates, shared on LinkedIn: "Today, I had the opportunity to…
Apr 12, 2024, 05:16 |
Drugs
Tanja Obradovic: Era of antibody drug conjugates just got even more exciting with the first tumor-agnostic approval for ADC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: "Era…
Apr 9, 2024, 12:53 |
Blog
Christiana Bardon: The AACR industry partnering event was a tremendous success
Christiana Bardon, Co-Managing Partner at MPM BioImpact, shared on their LinkedIn: ''The American Association for…
Apr 8, 2024, 16:01 |
Drugs
Rahul Gosain: Trastuzumab Deruxtecan now is FDA approved, Based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 8, 2024, 15:41 |
Drugs
Tom Powles: This seems an ambitious accelerated approval in UC
Tom Powles, Director of Barts Cancer Center, recently shared on X: "TDXD received FDA accelerated…
Apr 8, 2024, 07:46 |
Positive
Vivek Subbiah: OUR ACTION LEADER who keeps me inspired! Incredibly proud!
Vivek Subbiah recently shared on his LinkedIn page: "Before heading to the American Association for…
3
4
5
6
7
All:
138
Posts:
41 - 50
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube